Blake Borgeson - Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Blake Borgeson - trading volume in the past year for Recursion Pharmaceuticals, Inc.

Holdings reported by Blake Borgeson for Recursion Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 7.07M $54M $7.64 Nov 12, 2024 Direct
Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct Class A Common Stock

Transactions reported by Blake Borgeson for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.